ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3
Application 1143/MUMNP/2003 published 2006-05-05, filed 2003-12-15
The present invention relates to new compounds of formula (I) wherein Z, Y, X, P, Q, R, R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, R<7>, R<8>, R<9>, R<10>, R<11>, R<12>, A, m and n are defined as in any one of claims 1 to 3, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds for the treatment of conditions associated with glycogens synthase kinase-3 (GSK3). Drawing sheets. NIL Total Pages: 150 (FIG.-NIL)
Applicant
ASTRAZENECA AB
S-15185 SODERTALJE, SWEDEN
Inventor
1. STEFAN BERG 2. SVEN HELLBERG
International Info
Classification: C 07 D 213/73
Publication Number: WO 03/04472 A1
Priority Information
0102439-7 SWEDEN 2001-07-05